Skip to main content
Erschienen in: Journal of Neurology 5/2015

01.05.2015 | Review

Diagnosis of muscle diseases presenting with early respiratory failure

verfasst von: Gerald Pfeffer, Marcus Povitz, G. John Gibson, Patrick F. Chinnery

Erschienen in: Journal of Neurology | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Here we describe a clinical approach and differential diagnosis for chronic muscle diseases which include early respiratory failure as a prominent feature in their presentation (i.e. respiratory failure whilst still ambulant). These patients typically present to neurology or respiratory medicine out-patient clinics and a distinct differential diagnosis of neuromuscular aetiologies should be considered. Amyotrophic lateral sclerosis and myasthenia gravis are the important non-muscle diseases to consider, but once these have been excluded there remains a challenging differential diagnosis of muscle conditions, which will be the focus of this review. The key points in the diagnosis of these disorders are being aware of relevant symptoms, which are initially caused by nocturnal hypoventilation or diaphragmatic weakness; and identifying other features which direct further investigation. Important muscle diseases to identify, because their diagnosis has disease-specific management implications, include adult-onset Pompe disease, inflammatory myopathy, and sporadic adult-onset nemaline myopathy. Cases which are due to metabolic myopathy or muscular dystrophy are important to diagnose because of their implications for genetic counselling. Myopathy from sarcoidosis and colchicine each has a single reported case with this presentation, but should be considered because they are treatable. Disorders which have recently had their genetic aetiologies identified include hereditary myopathy with early respiratory failure (due to TTN mutations), the FHL1-related syndromes, and myofibrillar myopathy due to BAG3 mutation. Recently described syndromes include oculopharyngodistal muscular dystrophy that awaits genetic characterisation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Laghi F, Tobin MJ (2003) Disorders of the respiratory muscles. Am J Respir Crit Care Med 168(1):10–48PubMedCrossRef Laghi F, Tobin MJ (2003) Disorders of the respiratory muscles. Am J Respir Crit Care Med 168(1):10–48PubMedCrossRef
2.
Zurück zum Zitat Bourke SC, Gibson GJ (2002) Sleep and breathing in neuromuscular disease. Eur Respir J 19(6):1194–1201PubMedCrossRef Bourke SC, Gibson GJ (2002) Sleep and breathing in neuromuscular disease. Eur Respir J 19(6):1194–1201PubMedCrossRef
3.
Zurück zum Zitat Rochester DF, Esau SA (1994) Assessment of ventilatory function in patients with neuromuscular disease. Clin Chest Med 15(4):751–763PubMed Rochester DF, Esau SA (1994) Assessment of ventilatory function in patients with neuromuscular disease. Clin Chest Med 15(4):751–763PubMed
4.
Zurück zum Zitat Ambrosino N, Carpene N, Gherardi M (2009) Chronic respiratory care for neuromuscular diseases in adults. Eur Respir J 34(2):444–451PubMedCrossRef Ambrosino N, Carpene N, Gherardi M (2009) Chronic respiratory care for neuromuscular diseases in adults. Eur Respir J 34(2):444–451PubMedCrossRef
5.
Zurück zum Zitat Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK et al (2012) Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the sleep apnea definitions task force of the American academy of sleep medicine. J Clin Sleep Med 8(5):597–619PubMedCentralPubMed Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK et al (2012) Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the sleep apnea definitions task force of the American academy of sleep medicine. J Clin Sleep Med 8(5):597–619PubMedCentralPubMed
6.
Zurück zum Zitat Mokhlesi B, Tulaimat A, Faibussowitsch I, Wang Y, Evans AT (2007) Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath 11(2):117–124PubMedCrossRef Mokhlesi B, Tulaimat A, Faibussowitsch I, Wang Y, Evans AT (2007) Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath 11(2):117–124PubMedCrossRef
7.
Zurück zum Zitat American Thoracic Society/European Respiratory Society (2002) ATS/ERS statement on respiratory muscle testing. Am J Respir Crit Care Med 166(4):518–624CrossRef American Thoracic Society/European Respiratory Society (2002) ATS/ERS statement on respiratory muscle testing. Am J Respir Crit Care Med 166(4):518–624CrossRef
8.
Zurück zum Zitat Hutchinson D, Whyte K (2008) Neuromuscular disease and respiratory failure. Pract Neurol 8(4):229–237PubMedCrossRef Hutchinson D, Whyte K (2008) Neuromuscular disease and respiratory failure. Pract Neurol 8(4):229–237PubMedCrossRef
9.
Zurück zum Zitat Gautier G, Verschueren A, Monnier A, Attarian S, Salort-Campana E, Pouget J (2010) ALS with respiratory onset: clinical features and effects of non-invasive ventilation on the prognosis. Amyotroph Lateral Scler 11(4):379–382PubMedCrossRef Gautier G, Verschueren A, Monnier A, Attarian S, Salort-Campana E, Pouget J (2010) ALS with respiratory onset: clinical features and effects of non-invasive ventilation on the prognosis. Amyotroph Lateral Scler 11(4):379–382PubMedCrossRef
10.
Zurück zum Zitat Qureshi AI, Choundry MA, Mohammad Y, Chua HC, Yahia AM, Ulatowski JA et al (2004) Respiratory failure as a first presentation of myasthenia gravis. Med Sci Monit 10(12):CR684–CR689PubMed Qureshi AI, Choundry MA, Mohammad Y, Chua HC, Yahia AM, Ulatowski JA et al (2004) Respiratory failure as a first presentation of myasthenia gravis. Med Sci Monit 10(12):CR684–CR689PubMed
11.
Zurück zum Zitat Wang RY, Bodamer OA, Watson MS, Wilcox WR, ACMG Work Group on Diagnostic Confirmation of Lysosomal Storage Diseases (2011) Lysosomal storage diseases: diagnostic confirmation and management of presymptomatic individuals. Genet Med 13(5):457–484PubMedCrossRef Wang RY, Bodamer OA, Watson MS, Wilcox WR, ACMG Work Group on Diagnostic Confirmation of Lysosomal Storage Diseases (2011) Lysosomal storage diseases: diagnostic confirmation and management of presymptomatic individuals. Genet Med 13(5):457–484PubMedCrossRef
12.
Zurück zum Zitat Mellies U, Lofaso F (2009) Pompe disease: a neuromuscular disease with respiratory muscle involvement. Respir Med 103(4):477–484PubMedCrossRef Mellies U, Lofaso F (2009) Pompe disease: a neuromuscular disease with respiratory muscle involvement. Respir Med 103(4):477–484PubMedCrossRef
13.
Zurück zum Zitat Winkel LP, Hagemans ML, van Doorn PA, Loonen MC, Hop WJ, Reuser AJ et al (2005) The natural course of non-classic Pompe’s disease; a review of 225 published cases. J Neurol 252(8):875–884PubMedCrossRef Winkel LP, Hagemans ML, van Doorn PA, Loonen MC, Hop WJ, Reuser AJ et al (2005) The natural course of non-classic Pompe’s disease; a review of 225 published cases. J Neurol 252(8):875–884PubMedCrossRef
14.
Zurück zum Zitat Muller-Felber W, Horvath R, Gempel K, Podskarbi T, Shin Y, Pongratz D et al (2007) Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients. Neuromuscul Disord 17(9–10):698–706PubMedCrossRef Muller-Felber W, Horvath R, Gempel K, Podskarbi T, Shin Y, Pongratz D et al (2007) Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients. Neuromuscul Disord 17(9–10):698–706PubMedCrossRef
15.
Zurück zum Zitat American Association of Neuromuscular and Electrodiagnostic Medicine (2009) Diagnostic criteria for late-onset (childhood and adult) Pompe disease. Muscle Nerve 40(1):149–160CrossRef American Association of Neuromuscular and Electrodiagnostic Medicine (2009) Diagnostic criteria for late-onset (childhood and adult) Pompe disease. Muscle Nerve 40(1):149–160CrossRef
16.
Zurück zum Zitat Goldstein JL, Young SP, Changela M, Dickerson GH, Zhang H, Dai J et al (2009) Screening for Pompe disease using a rapid dried blood spot method: experience of a clinical diagnostic laboratory. Muscle Nerve 40(1):32–36PubMedCrossRef Goldstein JL, Young SP, Changela M, Dickerson GH, Zhang H, Dai J et al (2009) Screening for Pompe disease using a rapid dried blood spot method: experience of a clinical diagnostic laboratory. Muscle Nerve 40(1):32–36PubMedCrossRef
17.
Zurück zum Zitat Schoser BG, Muller-Hocker J, Horvath R, Gempel K, Pongratz D, Lochmuller H et al (2007) Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisited. Neuropathol Appl Neurobiol 33(5):544–559PubMed Schoser BG, Muller-Hocker J, Horvath R, Gempel K, Pongratz D, Lochmuller H et al (2007) Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisited. Neuropathol Appl Neurobiol 33(5):544–559PubMed
18.
Zurück zum Zitat van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ et al (2010) A randomized study of alglucosidase alfa in late-onset Pompe’s disease. N Engl J Med 362(15):1396–1406PubMedCrossRef van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ et al (2010) A randomized study of alglucosidase alfa in late-onset Pompe’s disease. N Engl J Med 362(15):1396–1406PubMedCrossRef
19.
Zurück zum Zitat Bembi B, Pisa FE, Confalonieri M, Ciana G, Fiumara A, Parini R et al (2010) Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II. J Inherit Metab Dis 33(6):727–735PubMedCrossRef Bembi B, Pisa FE, Confalonieri M, Ciana G, Fiumara A, Parini R et al (2010) Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II. J Inherit Metab Dis 33(6):727–735PubMedCrossRef
20.
Zurück zum Zitat de Vries JM, van der Beek NA, Kroos MA, Ozkan L, van Doorn PA, Richards SM et al (2010) High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa. Mol Genet Metab 101(4):338–345PubMedCrossRef de Vries JM, van der Beek NA, Kroos MA, Ozkan L, van Doorn PA, Richards SM et al (2010) High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa. Mol Genet Metab 101(4):338–345PubMedCrossRef
21.
Zurück zum Zitat Kishnani PS, Goldenberg PC, DeArmey SL, Heller J, Benjamin D, Young S et al (2010) Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants. Mol Genet Metab 99(1):26–33PubMedCentralPubMedCrossRef Kishnani PS, Goldenberg PC, DeArmey SL, Heller J, Benjamin D, Young S et al (2010) Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants. Mol Genet Metab 99(1):26–33PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Slonim AE, Bulone L, Goldberg T, Minikes J, Slonim E, Galanko J et al (2007) Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy. Muscle Nerve 35(1):70–77PubMedCrossRef Slonim AE, Bulone L, Goldberg T, Minikes J, Slonim E, Galanko J et al (2007) Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy. Muscle Nerve 35(1):70–77PubMedCrossRef
23.
Zurück zum Zitat Kobayashi H, Shimada Y, Ikegami M, Kawai T, Sakurai K, Urashima T et al (2010) Prognostic factors for the late onset Pompe disease with enzyme replacement therapy: from our experience of 4 cases including an autopsy case. Mol Genet Metab 100(1):14–19PubMedCrossRef Kobayashi H, Shimada Y, Ikegami M, Kawai T, Sakurai K, Urashima T et al (2010) Prognostic factors for the late onset Pompe disease with enzyme replacement therapy: from our experience of 4 cases including an autopsy case. Mol Genet Metab 100(1):14–19PubMedCrossRef
24.
Zurück zum Zitat Ravaglia S, Carlucci A, Danesino C (2010) Prognostic factors for late-onset Pompe disease with enzyme replacement therapy: the two sides of low BMI. Mol Genet Metab 100(4):388PubMedCrossRef Ravaglia S, Carlucci A, Danesino C (2010) Prognostic factors for late-onset Pompe disease with enzyme replacement therapy: the two sides of low BMI. Mol Genet Metab 100(4):388PubMedCrossRef
25.
Zurück zum Zitat de Filippi P, Ravaglia S, Bembi B, Costa A, Moglia A, Piccolo G et al (2010) The angiotensin-converting enzyme insertion/deletion polymorphism modifies the clinical outcome in patients with Pompe disease. Genet Med 12(4):206–211PubMedCrossRef de Filippi P, Ravaglia S, Bembi B, Costa A, Moglia A, Piccolo G et al (2010) The angiotensin-converting enzyme insertion/deletion polymorphism modifies the clinical outcome in patients with Pompe disease. Genet Med 12(4):206–211PubMedCrossRef
27.
Zurück zum Zitat Kaufmann P, Engelstad K, Wei Y, Kulikova R, Oskoui M, Battista V et al (2009) Protean phenotypic features of the A3243G mitochondrial DNA mutation. Arch Neurol 66(1):85–91PubMedCrossRef Kaufmann P, Engelstad K, Wei Y, Kulikova R, Oskoui M, Battista V et al (2009) Protean phenotypic features of the A3243G mitochondrial DNA mutation. Arch Neurol 66(1):85–91PubMedCrossRef
28.
Zurück zum Zitat Pfeffer G, Sirrs S, Wade NK, Mezei MM (2011) Multisystem disorder in late-onset chronic progressive external ophthalmoplegia. Can J Neurol Sci 38(1):119–123PubMedCrossRef Pfeffer G, Sirrs S, Wade NK, Mezei MM (2011) Multisystem disorder in late-onset chronic progressive external ophthalmoplegia. Can J Neurol Sci 38(1):119–123PubMedCrossRef
29.
Zurück zum Zitat Smits BW, Heijdra YF, Cuppen FW, van Engelen BG (2011) Nature and frequency of respiratory involvement in chronic progressive external ophthalmoplegia. J Neurol 258(11):2020–2025PubMedCentralPubMedCrossRef Smits BW, Heijdra YF, Cuppen FW, van Engelen BG (2011) Nature and frequency of respiratory involvement in chronic progressive external ophthalmoplegia. J Neurol 258(11):2020–2025PubMedCentralPubMedCrossRef
30.
Zurück zum Zitat Flaherty KR, Wald J, Weisman IM, Zeballos RJ, Schork MA, Blaivas M et al (2001) Unexplained exertional limitation: characterization of patients with a mitochondrial myopathy. Am J Respir Crit Care Med 164(3):425–432PubMedCrossRef Flaherty KR, Wald J, Weisman IM, Zeballos RJ, Schork MA, Blaivas M et al (2001) Unexplained exertional limitation: characterization of patients with a mitochondrial myopathy. Am J Respir Crit Care Med 164(3):425–432PubMedCrossRef
31.
Zurück zum Zitat Bindoff LA, Howell N, Poulton J, McCullough DA, Morten KJ, Lightowlers RN et al (1993) Abnormal RNA processing associated with a novel tRNA mutation in mitochondrial DNA. A potential disease mechanism. J Biol Chem 268(26):19559–19564PubMed Bindoff LA, Howell N, Poulton J, McCullough DA, Morten KJ, Lightowlers RN et al (1993) Abnormal RNA processing associated with a novel tRNA mutation in mitochondrial DNA. A potential disease mechanism. J Biol Chem 268(26):19559–19564PubMed
32.
Zurück zum Zitat Hadjigeorgiou GM, Kim SH, Fischbeck KH, Andreu AL, Berry GT, Bingham P et al (1999) A new mitochondrial DNA mutation (A3288G) in the tRNA(leu(UUR)) gene associated with familial myopathy. J Neurol Sci 164(2):153–157PubMedCrossRef Hadjigeorgiou GM, Kim SH, Fischbeck KH, Andreu AL, Berry GT, Bingham P et al (1999) A new mitochondrial DNA mutation (A3288G) in the tRNA(leu(UUR)) gene associated with familial myopathy. J Neurol Sci 164(2):153–157PubMedCrossRef
33.
Zurück zum Zitat Yang CC, Hwang CC, Pang CY, Wei YH (1998) Mitochondrial myopathy with predominant respiratory dysfunction in a patient with A3243G mutation in the mitochondrial tRNA(leu(UUR))gene. J Formos Med Assoc 97(10):715–719PubMed Yang CC, Hwang CC, Pang CY, Wei YH (1998) Mitochondrial myopathy with predominant respiratory dysfunction in a patient with A3243G mutation in the mitochondrial tRNA(leu(UUR))gene. J Formos Med Assoc 97(10):715–719PubMed
34.
Zurück zum Zitat Kleinle S, Schneider V, Moosmann P, Brandner S, Krahenbuhl S, Liechti-Gallati S (1998) A novel mitochondrial tRNA(phe) mutation inhibiting anticodon stem formation associated with a muscle disease. Biochem Biophys Res Commun 247(1):112–115PubMedCrossRef Kleinle S, Schneider V, Moosmann P, Brandner S, Krahenbuhl S, Liechti-Gallati S (1998) A novel mitochondrial tRNA(phe) mutation inhibiting anticodon stem formation associated with a muscle disease. Biochem Biophys Res Commun 247(1):112–115PubMedCrossRef
35.
Zurück zum Zitat Goto Y, Tojo M, Tohyama J, Horai S, Nonaka I (1992) A novel point mutation in the mitochondrial tRNA(leu)(UUR) gene in a family with mitochondrial myopathy. Ann Neurol 31(6):672–675PubMedCrossRef Goto Y, Tojo M, Tohyama J, Horai S, Nonaka I (1992) A novel point mutation in the mitochondrial tRNA(leu)(UUR) gene in a family with mitochondrial myopathy. Ann Neurol 31(6):672–675PubMedCrossRef
36.
Zurück zum Zitat Cros D, Palliyath S, DiMauro S, Ramirez C, Shamsnia M, Wizer B (1992) Respiratory failure revealing mitochondrial myopathy in adults. Chest 101(3):824–828PubMedCrossRef Cros D, Palliyath S, DiMauro S, Ramirez C, Shamsnia M, Wizer B (1992) Respiratory failure revealing mitochondrial myopathy in adults. Chest 101(3):824–828PubMedCrossRef
37.
Zurück zum Zitat Desnuelle C, Pellissier JF, Serratrice G, Pouget J (1988) Chronic progressive external ophthalmoplegia (CPEO) associated with diaphragm paralysis: successful treatment with coenzyme Q (CoQ). Neurology 38(suppl):102 Desnuelle C, Pellissier JF, Serratrice G, Pouget J (1988) Chronic progressive external ophthalmoplegia (CPEO) associated with diaphragm paralysis: successful treatment with coenzyme Q (CoQ). Neurology 38(suppl):102
38.
Zurück zum Zitat O’Brien A, Blaivas M, Albers J, Wald J, Watts C (1998) A case of respiratory muscle weakness due to cytochrome c oxidase enzyme deficiency. Eur Respir J 12(3):742–744PubMedCrossRef O’Brien A, Blaivas M, Albers J, Wald J, Watts C (1998) A case of respiratory muscle weakness due to cytochrome c oxidase enzyme deficiency. Eur Respir J 12(3):742–744PubMedCrossRef
39.
Zurück zum Zitat Baker SK, Vladutiu GD, Peltier WL, Isackson PJ, Tarnopolsky MA (2008) Metabolic myopathies discovered during investigations of statin myopathy. Can J Neurol Sci 35(1):94–97PubMedCrossRef Baker SK, Vladutiu GD, Peltier WL, Isackson PJ, Tarnopolsky MA (2008) Metabolic myopathies discovered during investigations of statin myopathy. Can J Neurol Sci 35(1):94–97PubMedCrossRef
40.
Zurück zum Zitat Manni R, Piccolo G, Banfi P, Cerveri I, Bruschi C, Zoia C et al (1991) Respiratory patterns during sleep in mitochondrial myopathies with ophthalmoplegia. Eur Neurol 31(1):12–17PubMedCrossRef Manni R, Piccolo G, Banfi P, Cerveri I, Bruschi C, Zoia C et al (1991) Respiratory patterns during sleep in mitochondrial myopathies with ophthalmoplegia. Eur Neurol 31(1):12–17PubMedCrossRef
41.
Zurück zum Zitat Carroll JE, Zwillich C, Weil JV, Brooke MH (1976) Depressed ventilatory response in oculocraniosomatic neuromuscular disease. Neurology 26(2):140–146PubMedCrossRef Carroll JE, Zwillich C, Weil JV, Brooke MH (1976) Depressed ventilatory response in oculocraniosomatic neuromuscular disease. Neurology 26(2):140–146PubMedCrossRef
42.
Zurück zum Zitat Barohn RJ, Clanton T, Sahenk Z, Mendell JR (1990) Recurrent respiratory insufficiency and depressed ventilatory drive complicating mitochondrial myopathies. Neurology 40(1):103–106PubMedCrossRef Barohn RJ, Clanton T, Sahenk Z, Mendell JR (1990) Recurrent respiratory insufficiency and depressed ventilatory drive complicating mitochondrial myopathies. Neurology 40(1):103–106PubMedCrossRef
43.
Zurück zum Zitat Feit H, Kirkpatrick J, Van Woert MH, Pandian G (1983) Myoclonus, ataxia, and hypoventilation: response to L-5-hydroxytryptophan. Neurology 33(1):109–112PubMedCrossRef Feit H, Kirkpatrick J, Van Woert MH, Pandian G (1983) Myoclonus, ataxia, and hypoventilation: response to L-5-hydroxytryptophan. Neurology 33(1):109–112PubMedCrossRef
44.
Zurück zum Zitat Tatsumi C, Takahashi M, Yorifuji S, Nishikawa Y, Kitaguchi M, Hashimoto S et al (1988) Mitochondrial encephalomyopathy with sleep apnea. Eur Neurol 28(2):64–69PubMedCrossRef Tatsumi C, Takahashi M, Yorifuji S, Nishikawa Y, Kitaguchi M, Hashimoto S et al (1988) Mitochondrial encephalomyopathy with sleep apnea. Eur Neurol 28(2):64–69PubMedCrossRef
45.
Zurück zum Zitat Sembrano E, Barthlen GM, Wallace S, Lamm C (1997) Polysomnographic findings in a patient with the mitochondrial encephalomyopathy NARP. Neurology 49(6):1714–1717PubMedCrossRef Sembrano E, Barthlen GM, Wallace S, Lamm C (1997) Polysomnographic findings in a patient with the mitochondrial encephalomyopathy NARP. Neurology 49(6):1714–1717PubMedCrossRef
46.
Zurück zum Zitat Voduc N, Webb KA, D’Arsigny C, McBride I, O’Donnell DE (2004) McArdle’s disease presenting as unexplained dyspnea in a young woman. Can Respir J 11(2):163–167PubMed Voduc N, Webb KA, D’Arsigny C, McBride I, O’Donnell DE (2004) McArdle’s disease presenting as unexplained dyspnea in a young woman. Can Respir J 11(2):163–167PubMed
47.
Zurück zum Zitat Kiechl S, Willeit J, Vogel W, Kohlendorfer U, Poewe W (1999) Reversible severe myopathy of respiratory muscles due to adult-onset type III glycogenosis. Neuromuscul Disord 9(6–7):408–410PubMedCrossRef Kiechl S, Willeit J, Vogel W, Kohlendorfer U, Poewe W (1999) Reversible severe myopathy of respiratory muscles due to adult-onset type III glycogenosis. Neuromuscul Disord 9(6–7):408–410PubMedCrossRef
48.
Zurück zum Zitat Kaminsky P, Poussel M, Pruna L, Deibener J, Chenuel B, Brembilla-Perrot B (2011) Organ dysfunction and muscular disability in myotonic dystrophy type 1. Medicine (Baltimore) 90(4):262–268CrossRef Kaminsky P, Poussel M, Pruna L, Deibener J, Chenuel B, Brembilla-Perrot B (2011) Organ dysfunction and muscular disability in myotonic dystrophy type 1. Medicine (Baltimore) 90(4):262–268CrossRef
49.
Zurück zum Zitat Jammes Y, Pouget J, Grimaud C, Serratrice G (1985) Pulmonary function and electromyographic study of respiratory muscles in myotonic dystrophy. Muscle Nerve 8(7):586–594PubMedCrossRef Jammes Y, Pouget J, Grimaud C, Serratrice G (1985) Pulmonary function and electromyographic study of respiratory muscles in myotonic dystrophy. Muscle Nerve 8(7):586–594PubMedCrossRef
50.
Zurück zum Zitat Laberge L, Begin P, Dauvilliers Y, Beaudry M, Laforte M, Jean S et al (2009) A polysomnographic study of daytime sleepiness in myotonic dystrophy type 1. J Neurol Neurosurg Psychiatry 80(6):642–646PubMedCrossRef Laberge L, Begin P, Dauvilliers Y, Beaudry M, Laforte M, Jean S et al (2009) A polysomnographic study of daytime sleepiness in myotonic dystrophy type 1. J Neurol Neurosurg Psychiatry 80(6):642–646PubMedCrossRef
51.
Zurück zum Zitat Yu H, Laberge L, Jaussent I, Bayard S, Scholtz S, Raoul M et al (2011) Daytime sleepiness and REM sleep characteristics in myotonic dystrophy: a case–control study. Sleep 34(2):165–170PubMedCentralPubMed Yu H, Laberge L, Jaussent I, Bayard S, Scholtz S, Raoul M et al (2011) Daytime sleepiness and REM sleep characteristics in myotonic dystrophy: a case–control study. Sleep 34(2):165–170PubMedCentralPubMed
52.
Zurück zum Zitat Giubilei F, Antonini G, Bastianello S, Morino S, Paolillo A, Fiorelli M et al (1999) Excessive daytime sleepiness in myotonic dystrophy. J Neurol Sci 164(1):60–63PubMedCrossRef Giubilei F, Antonini G, Bastianello S, Morino S, Paolillo A, Fiorelli M et al (1999) Excessive daytime sleepiness in myotonic dystrophy. J Neurol Sci 164(1):60–63PubMedCrossRef
53.
Zurück zum Zitat van der Meche FG, Bogaard JM, van der Sluys JC, Schimsheimer RJ, Ververs CC, Busch HF (1994) Daytime sleep in myotonic dystrophy is not caused by sleep apnoea. J Neurol Neurosurg Psychiatry 57(5):626–628PubMedCentralPubMedCrossRef van der Meche FG, Bogaard JM, van der Sluys JC, Schimsheimer RJ, Ververs CC, Busch HF (1994) Daytime sleep in myotonic dystrophy is not caused by sleep apnoea. J Neurol Neurosurg Psychiatry 57(5):626–628PubMedCentralPubMedCrossRef
54.
Zurück zum Zitat Romigi A, Izzi F, Pisani V, Placidi F, Pisani LR, Marciani MG et al (2011) Sleep disorders in adult-onset myotonic dystrophy type 1: a controlled polysomnographic study. Eur J Neurol 18(9):1139–1145PubMedCrossRef Romigi A, Izzi F, Pisani V, Placidi F, Pisani LR, Marciani MG et al (2011) Sleep disorders in adult-onset myotonic dystrophy type 1: a controlled polysomnographic study. Eur J Neurol 18(9):1139–1145PubMedCrossRef
55.
Zurück zum Zitat Kiyan E, Okumus G, Cuhadaroglu C, Deymeer F (2010) Sleep apnea in adult myotonic dystrophy patients who have no excessive daytime sleepiness. Sleep Breath 14(1):19–24PubMedCrossRef Kiyan E, Okumus G, Cuhadaroglu C, Deymeer F (2010) Sleep apnea in adult myotonic dystrophy patients who have no excessive daytime sleepiness. Sleep Breath 14(1):19–24PubMedCrossRef
56.
Zurück zum Zitat Nugent AM, Smith IE, Shneerson JM (2002) Domiciliary-assisted ventilation in patients with myotonic dystrophy. Chest 121(2):459–464PubMedCrossRef Nugent AM, Smith IE, Shneerson JM (2002) Domiciliary-assisted ventilation in patients with myotonic dystrophy. Chest 121(2):459–464PubMedCrossRef
57.
Zurück zum Zitat Annane D, Moore DH, Barnes PR, Miller RG (2006) Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy. Cochrane Database Syst Rev 3:CD003218PubMed Annane D, Moore DH, Barnes PR, Miller RG (2006) Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy. Cochrane Database Syst Rev 3:CD003218PubMed
58.
Zurück zum Zitat Orlikowski D, Chevret S, Quera-Salva MA, Laforet P, Lofaso F, Verschueren A et al (2009) Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial. Clin Ther 31(8):1765–1773PubMedCrossRef Orlikowski D, Chevret S, Quera-Salva MA, Laforet P, Lofaso F, Verschueren A et al (2009) Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial. Clin Ther 31(8):1765–1773PubMedCrossRef
59.
Zurück zum Zitat Mercuri E, Brockington M, Straub V, Quijano-Roy S, Yuva Y, Herrmann R et al (2003) Phenotypic spectrum associated with mutations in the fukutin-related protein gene. Ann Neurol 53(4):537–542PubMedCrossRef Mercuri E, Brockington M, Straub V, Quijano-Roy S, Yuva Y, Herrmann R et al (2003) Phenotypic spectrum associated with mutations in the fukutin-related protein gene. Ann Neurol 53(4):537–542PubMedCrossRef
60.
Zurück zum Zitat Poppe M, Cree L, Bourke J, Eagle M, Anderson LV, Birchall D et al (2003) The phenotype of limb-girdle muscular dystrophy type 2I. Neurology 60(8):1246–1251PubMedCrossRef Poppe M, Cree L, Bourke J, Eagle M, Anderson LV, Birchall D et al (2003) The phenotype of limb-girdle muscular dystrophy type 2I. Neurology 60(8):1246–1251PubMedCrossRef
61.
Zurück zum Zitat Bourteel H, Vermersch P, Cuisset JM, Maurage CA, Laforet P, Richard P et al (2009) Clinical and mutational spectrum of limb-girdle muscular dystrophy type 2I in 11 French patients. J Neurol Neurosurg Psychiatry 80(12):1405–1408PubMedCrossRef Bourteel H, Vermersch P, Cuisset JM, Maurage CA, Laforet P, Richard P et al (2009) Clinical and mutational spectrum of limb-girdle muscular dystrophy type 2I in 11 French patients. J Neurol Neurosurg Psychiatry 80(12):1405–1408PubMedCrossRef
62.
Zurück zum Zitat Boito CA, Melacini P, Vianello A, Prandini P, Gavassini BF, Bagattin A et al (2005) Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I. Arch Neurol 62(12):1894–1899PubMedCrossRef Boito CA, Melacini P, Vianello A, Prandini P, Gavassini BF, Bagattin A et al (2005) Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I. Arch Neurol 62(12):1894–1899PubMedCrossRef
63.
Zurück zum Zitat Poppe M, Bourke J, Eagle M, Frosk P, Wrogemann K, Greenberg C et al (2004) Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I. Ann Neurol 56(5):738–741PubMedCrossRef Poppe M, Bourke J, Eagle M, Frosk P, Wrogemann K, Greenberg C et al (2004) Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I. Ann Neurol 56(5):738–741PubMedCrossRef
64.
Zurück zum Zitat Patel ND, Jannapureddy SR, Hwang W, Chaudhry I, Boriek AM (2003) Altered muscle force and stiffness of skeletal muscles in alpha-sarcoglycan-deficient mice. Am J Physiol Cell Physiol 284(4):C962–C968PubMedCrossRef Patel ND, Jannapureddy SR, Hwang W, Chaudhry I, Boriek AM (2003) Altered muscle force and stiffness of skeletal muscles in alpha-sarcoglycan-deficient mice. Am J Physiol Cell Physiol 284(4):C962–C968PubMedCrossRef
65.
Zurück zum Zitat Politano L, Nigro V, Passamano L, Petretta V, Comi LI, Papparella S et al (2001) Evaluation of cardiac and respiratory involvement in sarcoglycanopathies. Neuromuscul Disord 11(2):178–185PubMedCrossRef Politano L, Nigro V, Passamano L, Petretta V, Comi LI, Papparella S et al (2001) Evaluation of cardiac and respiratory involvement in sarcoglycanopathies. Neuromuscul Disord 11(2):178–185PubMedCrossRef
66.
Zurück zum Zitat Walter MC, Dekomien G, Schlotter-Weigel B, Reilich P, Pongratz D, Muller-Felber W et al (2004) Respiratory insufficiency as a presenting symptom of LGMD2D in adulthood. Acta Myol 23(1):1–5PubMed Walter MC, Dekomien G, Schlotter-Weigel B, Reilich P, Pongratz D, Muller-Felber W et al (2004) Respiratory insufficiency as a presenting symptom of LGMD2D in adulthood. Acta Myol 23(1):1–5PubMed
68.
Zurück zum Zitat Kley RA, Hellenbroich Y, van der Ven PF, Furst DO, Huebner A, Bruchertseifer V et al (2007) Clinical and morphological phenotype of the filamin myopathy: a study of 31 german patients. Brain 130(Pt 12):3250–3264PubMedCrossRef Kley RA, Hellenbroich Y, van der Ven PF, Furst DO, Huebner A, Bruchertseifer V et al (2007) Clinical and morphological phenotype of the filamin myopathy: a study of 31 german patients. Brain 130(Pt 12):3250–3264PubMedCrossRef
69.
Zurück zum Zitat Walter MC, Reilich P, Huebner A, Fischer D, Schroder R, Vorgerd M et al (2007) Scapuloperoneal syndrome type kaeser and a wide phenotypic spectrum of adult-onset, dominant myopathies are associated with the desmin mutation R350P. Brain 130(Pt 6):1485–1496PubMedCrossRef Walter MC, Reilich P, Huebner A, Fischer D, Schroder R, Vorgerd M et al (2007) Scapuloperoneal syndrome type kaeser and a wide phenotypic spectrum of adult-onset, dominant myopathies are associated with the desmin mutation R350P. Brain 130(Pt 6):1485–1496PubMedCrossRef
70.
Zurück zum Zitat Selcen D, Engel AG (2003) Myofibrillar myopathy caused by novel dominant negative alpha B-crystallin mutations. Ann Neurol 54(6):804–810PubMedCrossRef Selcen D, Engel AG (2003) Myofibrillar myopathy caused by novel dominant negative alpha B-crystallin mutations. Ann Neurol 54(6):804–810PubMedCrossRef
71.
Zurück zum Zitat Selcen D, Muntoni F, Burton BK, Pegoraro E, Sewry C, Bite AV et al (2009) Mutation in BAG3 causes severe dominant childhood muscular dystrophy. Ann Neurol 65(1):83–89PubMedCentralPubMedCrossRef Selcen D, Muntoni F, Burton BK, Pegoraro E, Sewry C, Bite AV et al (2009) Mutation in BAG3 causes severe dominant childhood muscular dystrophy. Ann Neurol 65(1):83–89PubMedCentralPubMedCrossRef
72.
Zurück zum Zitat Olive M, Odgerel Z, Martinez A, Poza JJ, Bragado FG, Zabalza RJ et al (2011) Clinical and myopathological evaluation of early- and late-onset subtypes of myofibrillar myopathy. Neuromuscul Disord 21:533–542PubMedCrossRef Olive M, Odgerel Z, Martinez A, Poza JJ, Bragado FG, Zabalza RJ et al (2011) Clinical and myopathological evaluation of early- and late-onset subtypes of myofibrillar myopathy. Neuromuscul Disord 21:533–542PubMedCrossRef
73.
Zurück zum Zitat Boriek AM, Capetanaki Y, Hwang W, Officer T, Badshah M, Rodarte J et al (2001) Desmin integrates the three-dimensional mechanical properties of muscles. Am J Physiol Cell Physiol 280(1):C46–C52PubMed Boriek AM, Capetanaki Y, Hwang W, Officer T, Badshah M, Rodarte J et al (2001) Desmin integrates the three-dimensional mechanical properties of muscles. Am J Physiol Cell Physiol 280(1):C46–C52PubMed
74.
Zurück zum Zitat Palmio J, Evila A, Chapon F, Tasca G, Xiang F, Bradvik B et al (2013) Hereditary myopathy with early respiratory failure: occurrence in various populations. J Neurol Neurosurg Psychiatry 85(3):345–353 Palmio J, Evila A, Chapon F, Tasca G, Xiang F, Bradvik B et al (2013) Hereditary myopathy with early respiratory failure: occurrence in various populations. J Neurol Neurosurg Psychiatry 85(3):345–353
75.
Zurück zum Zitat Pfeffer G, Barresi R, Wilson IJ, Hardy SA, Griffin H, Hudson J et al (2014) Titin founder mutation is a common cause of myofibrillar myopathy with early respiratory failure. J Neurol Neurosurg Psychiatry 85(3):331–338 Pfeffer G, Barresi R, Wilson IJ, Hardy SA, Griffin H, Hudson J et al (2014) Titin founder mutation is a common cause of myofibrillar myopathy with early respiratory failure. J Neurol Neurosurg Psychiatry 85(3):331–338
76.
Zurück zum Zitat Izumi R, Niihori T, Aoki Y, Suzuki N, Kato M, Warita H et al (2013) Exome sequencing identifies a novel TTN mutation in a family with hereditary myopathy with early respiratory failure. J Hum Genet 58(5):259–266 Izumi R, Niihori T, Aoki Y, Suzuki N, Kato M, Warita H et al (2013) Exome sequencing identifies a novel TTN mutation in a family with hereditary myopathy with early respiratory failure. J Hum Genet 58(5):259–266
77.
Zurück zum Zitat Pfeffer G, Elliott HR, Griffin H, Barresi R, Miller J, Marsh J et al (2012) Titin mutation segregates with hereditary myopathy with early respiratory failure. Brain 135(Pt 6):1695–1713PubMedCentralPubMedCrossRef Pfeffer G, Elliott HR, Griffin H, Barresi R, Miller J, Marsh J et al (2012) Titin mutation segregates with hereditary myopathy with early respiratory failure. Brain 135(Pt 6):1695–1713PubMedCentralPubMedCrossRef
78.
Zurück zum Zitat Ohlsson M, Hedberg C, Bradvik B, Lindberg C, Tajsharghi H, Danielsson O et al (2012) Hereditary myopathy with early respiratory failure associated with a mutation in A-band titin. Brain 135(Pt 6):1682–1694PubMedCrossRef Ohlsson M, Hedberg C, Bradvik B, Lindberg C, Tajsharghi H, Danielsson O et al (2012) Hereditary myopathy with early respiratory failure associated with a mutation in A-band titin. Brain 135(Pt 6):1682–1694PubMedCrossRef
79.
Zurück zum Zitat Toro C, Olive M, Dalakas MC, Sivakumar K, Bilbao JM, Tyndel F et al (2013) Exome sequencing identifies titin mutations causing hereditary myopathy with early respiratory failure (HMERF) in families of diverse ethnic origins. BMC Neurol 13:29PubMedCentralPubMedCrossRef Toro C, Olive M, Dalakas MC, Sivakumar K, Bilbao JM, Tyndel F et al (2013) Exome sequencing identifies titin mutations causing hereditary myopathy with early respiratory failure (HMERF) in families of diverse ethnic origins. BMC Neurol 13:29PubMedCentralPubMedCrossRef
80.
Zurück zum Zitat Lange S, Xiang F, Yakovenko A, Vihola A, Hackman P, Rostkova E et al (2005) The kinase domain of titin controls muscle gene expression and protein turnover. Science 308(5728):1599–1603PubMedCrossRef Lange S, Xiang F, Yakovenko A, Vihola A, Hackman P, Rostkova E et al (2005) The kinase domain of titin controls muscle gene expression and protein turnover. Science 308(5728):1599–1603PubMedCrossRef
81.
Zurück zum Zitat Hedberg C, Melberg A, Dahlbom K, Oldfors A (2013) Hereditary myopathy with early respiratory failure is caused by mutations in the titin FN3 119 domain. Brain 137(Pt 4):e270 Hedberg C, Melberg A, Dahlbom K, Oldfors A (2013) Hereditary myopathy with early respiratory failure is caused by mutations in the titin FN3 119 domain. Brain 137(Pt 4):e270
82.
Zurück zum Zitat Lehtokari VL, Pelin K, Donner K, Voit T, Rudnik-Schoneborn S, Stoetter M et al (2008) Identification of a founder mutation in TPM3 in nemaline myopathy patients of turkish origin. Eur J Hum Genet 16(9):1055–1061PubMedCrossRef Lehtokari VL, Pelin K, Donner K, Voit T, Rudnik-Schoneborn S, Stoetter M et al (2008) Identification of a founder mutation in TPM3 in nemaline myopathy patients of turkish origin. Eur J Hum Genet 16(9):1055–1061PubMedCrossRef
83.
Zurück zum Zitat Clarke NF, Kolski H, Dye DE, Lim E, Smith RL, Patel R et al (2008) Mutations in TPM3 are a common cause of congenital fiber type disproportion. Ann Neurol 63(3):329–337PubMedCrossRef Clarke NF, Kolski H, Dye DE, Lim E, Smith RL, Patel R et al (2008) Mutations in TPM3 are a common cause of congenital fiber type disproportion. Ann Neurol 63(3):329–337PubMedCrossRef
84.
Zurück zum Zitat Laing NG, Wilton SD, Akkari PA, Dorosz S, Boundy K, Kneebone C et al (1995) A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy NEM1. Nat Genet 10(2):249PubMed Laing NG, Wilton SD, Akkari PA, Dorosz S, Boundy K, Kneebone C et al (1995) A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy NEM1. Nat Genet 10(2):249PubMed
85.
Zurück zum Zitat De Paula AM, Franques J, Fernandez C, Monnier N, Lunardi J, Pellissier JF et al (2009) A TPM3 mutation causing cap myopathy. Neuromuscul Disord 19(10):685–688PubMedCrossRef De Paula AM, Franques J, Fernandez C, Monnier N, Lunardi J, Pellissier JF et al (2009) A TPM3 mutation causing cap myopathy. Neuromuscul Disord 19(10):685–688PubMedCrossRef
86.
Zurück zum Zitat Waddell LB, Kreissl M, Kornberg A, Kennedy P, McLean C, Labarre-Vila A et al (2010) Evidence for a dominant negative disease mechanism in cap myopathy due to TPM3. Neuromuscul Disord 20(7):464–466PubMedCrossRef Waddell LB, Kreissl M, Kornberg A, Kennedy P, McLean C, Labarre-Vila A et al (2010) Evidence for a dominant negative disease mechanism in cap myopathy due to TPM3. Neuromuscul Disord 20(7):464–466PubMedCrossRef
87.
Zurück zum Zitat Munot P, Lashley D, Jungbluth H, Feng L, Pitt M, Robb SA et al (2010) Congenital fibre type disproportion associated with mutations in the tropomyosin 3 (TPM3) gene mimicking congenital myasthenia. Neuromuscul Disord 20(12):796–800PubMedCrossRef Munot P, Lashley D, Jungbluth H, Feng L, Pitt M, Robb SA et al (2010) Congenital fibre type disproportion associated with mutations in the tropomyosin 3 (TPM3) gene mimicking congenital myasthenia. Neuromuscul Disord 20(12):796–800PubMedCrossRef
88.
Zurück zum Zitat Lawlor MW, Dechene ET, Roumm E, Geggel AS, Moghadaszadeh B, Beggs AH (2010) Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion. Hum Mutat 31(2):176–183PubMedCentralPubMedCrossRef Lawlor MW, Dechene ET, Roumm E, Geggel AS, Moghadaszadeh B, Beggs AH (2010) Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion. Hum Mutat 31(2):176–183PubMedCentralPubMedCrossRef
89.
Zurück zum Zitat Cowling BS, Cottle DL, Wilding BR, D’Arcy CE, Mitchell CA, McGrath MJ (2011) Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features. Neuromuscul Disord 21(4):237–251PubMedCrossRef Cowling BS, Cottle DL, Wilding BR, D’Arcy CE, Mitchell CA, McGrath MJ (2011) Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features. Neuromuscul Disord 21(4):237–251PubMedCrossRef
90.
Zurück zum Zitat Sarkozy A, Windpassinger C, Hudson J, Dougan CF, Lecky B, Hilton-Jones D et al (2011) Phenotypic heterogeneity in british patients with a founder mutation in the FHL1 gene. Eur J Hum Genet 19(10):1038–1044PubMedCentralPubMedCrossRef Sarkozy A, Windpassinger C, Hudson J, Dougan CF, Lecky B, Hilton-Jones D et al (2011) Phenotypic heterogeneity in british patients with a founder mutation in the FHL1 gene. Eur J Hum Genet 19(10):1038–1044PubMedCentralPubMedCrossRef
91.
Zurück zum Zitat Selcen D, Bromberg MB, Chin SS, Engel AG (2011) Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy. Neurology 77(22):1951–1959PubMedCentralPubMedCrossRef Selcen D, Bromberg MB, Chin SS, Engel AG (2011) Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy. Neurology 77(22):1951–1959PubMedCentralPubMedCrossRef
92.
Zurück zum Zitat Avram C, Angus R, Ford V, Ward K, Parker R (2011) XMPMA: acute on chronic ventilatory failure managed successfully with non-invasive ventilation. JRSM Short Rep 2(11):84PubMedCentralPubMedCrossRef Avram C, Angus R, Ford V, Ward K, Parker R (2011) XMPMA: acute on chronic ventilatory failure managed successfully with non-invasive ventilation. JRSM Short Rep 2(11):84PubMedCentralPubMedCrossRef
93.
Zurück zum Zitat Windpassinger C, Schoser B, Straub V, Hochmeister S, Noor A, Lohberger B et al (2008) An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. Am J Hum Genet 82(1):88–99PubMedCentralPubMedCrossRef Windpassinger C, Schoser B, Straub V, Hochmeister S, Noor A, Lohberger B et al (2008) An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. Am J Hum Genet 82(1):88–99PubMedCentralPubMedCrossRef
94.
95.
Zurück zum Zitat van der Sluijs BM, ter Laak HJ, Scheffer H, van der Maarel SM, van Engelen BG (2004) Autosomal recessive oculopharyngodistal myopathy: a distinct phenotypical, histological, and genetic entity. J Neurol Neurosurg Psychiatry 75(10):1499–1501PubMedCentralPubMedCrossRef van der Sluijs BM, ter Laak HJ, Scheffer H, van der Maarel SM, van Engelen BG (2004) Autosomal recessive oculopharyngodistal myopathy: a distinct phenotypical, histological, and genetic entity. J Neurol Neurosurg Psychiatry 75(10):1499–1501PubMedCentralPubMedCrossRef
96.
Zurück zum Zitat Durmus H, Laval SH, Deymeer F, Parman Y, Kiyan E, Gokyigiti M et al (2011) Oculopharyngodistal myopathy is a distinct entity: clinical and genetic features of 47 patients. Neurology 76(3):227–235PubMedCrossRef Durmus H, Laval SH, Deymeer F, Parman Y, Kiyan E, Gokyigiti M et al (2011) Oculopharyngodistal myopathy is a distinct entity: clinical and genetic features of 47 patients. Neurology 76(3):227–235PubMedCrossRef
97.
Zurück zum Zitat Teixeira A, Cherin P, Demoule A, Levy-Soussan M, Straus C, Verin E et al (2005) Diaphragmatic dysfunction in patients with idiopathic inflammatory myopathies. Neuromuscul Disord 15(1):32–39PubMedCrossRef Teixeira A, Cherin P, Demoule A, Levy-Soussan M, Straus C, Verin E et al (2005) Diaphragmatic dysfunction in patients with idiopathic inflammatory myopathies. Neuromuscul Disord 15(1):32–39PubMedCrossRef
98.
Zurück zum Zitat Marie I, Hachulla E, Cherin P, Hellot MF, Herson S, Levesque H et al (2005) Opportunistic infections in polymyositis and dermatomyositis. Arthritis Rheum 53(2):155–165PubMedCrossRef Marie I, Hachulla E, Cherin P, Hellot MF, Herson S, Levesque H et al (2005) Opportunistic infections in polymyositis and dermatomyositis. Arthritis Rheum 53(2):155–165PubMedCrossRef
99.
Zurück zum Zitat Kalluri M, Oddis CV (2010) Pulmonary manifestations of the idiopathic inflammatory myopathies. Clin Chest Med 31(3):501–512PubMedCrossRef Kalluri M, Oddis CV (2010) Pulmonary manifestations of the idiopathic inflammatory myopathies. Clin Chest Med 31(3):501–512PubMedCrossRef
100.
Zurück zum Zitat Blumbergs PC, Byrne E, Kakulas BA (1984) Polymyositis presenting with respiratory failure. J Neurol Sci 65(2):221–229PubMedCrossRef Blumbergs PC, Byrne E, Kakulas BA (1984) Polymyositis presenting with respiratory failure. J Neurol Sci 65(2):221–229PubMedCrossRef
101.
Zurück zum Zitat Sano M, Suzuki M, Sato M, Sakamoto T, Uchigata M (1994) Fatal respiratory failure due to polymyositis. Intern Med 33(3):185–187PubMedCrossRef Sano M, Suzuki M, Sato M, Sakamoto T, Uchigata M (1994) Fatal respiratory failure due to polymyositis. Intern Med 33(3):185–187PubMedCrossRef
102.
Zurück zum Zitat Dejardin Botelho A, Perez T, Pouwels S, Wallaert B, Hachulla E, Tillie-Leblond I (2008) Inspiratory muscle myopathy and antisynthetase syndrome. Rev Med Intern 29(4):325–327CrossRef Dejardin Botelho A, Perez T, Pouwels S, Wallaert B, Hachulla E, Tillie-Leblond I (2008) Inspiratory muscle myopathy and antisynthetase syndrome. Rev Med Intern 29(4):325–327CrossRef
103.
Zurück zum Zitat Selva-O’Callaghan A, Sanchez-Sitjes L, Munoz-Gall X, Mijares-Boeckh-Behrens T, Solans-Laque R, Angel Bosch-Gil J et al (2000) Respiratory failure due to muscle weakness in inflammatory myopathies: maintenance therapy with home mechanical ventilation. Rheumatology (Oxford) 39(8):914–916CrossRef Selva-O’Callaghan A, Sanchez-Sitjes L, Munoz-Gall X, Mijares-Boeckh-Behrens T, Solans-Laque R, Angel Bosch-Gil J et al (2000) Respiratory failure due to muscle weakness in inflammatory myopathies: maintenance therapy with home mechanical ventilation. Rheumatology (Oxford) 39(8):914–916CrossRef
104.
Zurück zum Zitat Sherer Y, Shepshelovich D, Shalev T, Haviv Y, Segal E, Ehrenfeld M et al (2007) Outcome of patients having dermatomyositis admitted to the intensive care unit. Clin Rheumatol 26(11):1851–1855PubMedCrossRef Sherer Y, Shepshelovich D, Shalev T, Haviv Y, Segal E, Ehrenfeld M et al (2007) Outcome of patients having dermatomyositis admitted to the intensive care unit. Clin Rheumatol 26(11):1851–1855PubMedCrossRef
105.
Zurück zum Zitat Cohen R, Lipper S, Dantzker DR (1993) Inclusion body myositis as a cause of respiratory failure. Chest 104(3):975–977PubMedCrossRef Cohen R, Lipper S, Dantzker DR (1993) Inclusion body myositis as a cause of respiratory failure. Chest 104(3):975–977PubMedCrossRef
106.
Zurück zum Zitat Ryan MM, Schnell C, Strickland CD, Shield LK, Morgan G, Iannaccone ST et al (2001) Nemaline myopathy: a clinical study of 143 cases. Ann Neurol 50(3):312–320PubMedCrossRef Ryan MM, Schnell C, Strickland CD, Shield LK, Morgan G, Iannaccone ST et al (2001) Nemaline myopathy: a clinical study of 143 cases. Ann Neurol 50(3):312–320PubMedCrossRef
107.
Zurück zum Zitat Chahin N, Selcen D, Engel AG (2005) Sporadic late onset nemaline myopathy. Neurology 65(8):1158–1164PubMedCrossRef Chahin N, Selcen D, Engel AG (2005) Sporadic late onset nemaline myopathy. Neurology 65(8):1158–1164PubMedCrossRef
108.
Zurück zum Zitat Dalakas MC, Pezeshkpour GH, Flaherty M (1987) Progressive nemaline (rod) myopathy associated with HIV infection. N Engl J Med 317(25):1602–1603PubMedCrossRef Dalakas MC, Pezeshkpour GH, Flaherty M (1987) Progressive nemaline (rod) myopathy associated with HIV infection. N Engl J Med 317(25):1602–1603PubMedCrossRef
109.
110.
Zurück zum Zitat Gyure KA, Prayson RA, Estes ML (1997) Adult-onset nemaline myopathy: a case report and review of the literature. Arch Pathol Lab Med 121(11):1210–1213PubMed Gyure KA, Prayson RA, Estes ML (1997) Adult-onset nemaline myopathy: a case report and review of the literature. Arch Pathol Lab Med 121(11):1210–1213PubMed
111.
Zurück zum Zitat Falga-Tirado C, Perez-Peman P, Ordi-Ros J, Bofill JM, Balcells E (1995) Adult onset of nemaline myopathy presenting as respiratory insufficiency. Respiration 62(6):353–354PubMedCrossRef Falga-Tirado C, Perez-Peman P, Ordi-Ros J, Bofill JM, Balcells E (1995) Adult onset of nemaline myopathy presenting as respiratory insufficiency. Respiration 62(6):353–354PubMedCrossRef
112.
Zurück zum Zitat Kudou M, Kobayashi Y, Yamashita K, Kita H, Yasuba H, Hamada K (2006) Two cases of nemaline myopathy diagnosed after episodes of respiratory failure. Nihon Kokyuki Gakkai Zasshi 44(6):474–478PubMed Kudou M, Kobayashi Y, Yamashita K, Kita H, Yasuba H, Hamada K (2006) Two cases of nemaline myopathy diagnosed after episodes of respiratory failure. Nihon Kokyuki Gakkai Zasshi 44(6):474–478PubMed
113.
Zurück zum Zitat Kelly E, Farrell MA, McElvaney NG (2008) Adult-onset nemaline myopathy presenting as respiratory failure. Respir Care 53(11):1490–1494PubMed Kelly E, Farrell MA, McElvaney NG (2008) Adult-onset nemaline myopathy presenting as respiratory failure. Respir Care 53(11):1490–1494PubMed
114.
Zurück zum Zitat Jungbluth H, Sewry CA, Brown SC, Nowak KJ, Laing NG, Wallgren-Pettersson C et al (2001) Mild phenotype of nemaline myopathy with sleep hypoventilation due to a mutation in the skeletal muscle alpha-actin (ACTA1) gene. Neuromuscul Disord 11(1):35–40PubMedCrossRef Jungbluth H, Sewry CA, Brown SC, Nowak KJ, Laing NG, Wallgren-Pettersson C et al (2001) Mild phenotype of nemaline myopathy with sleep hypoventilation due to a mutation in the skeletal muscle alpha-actin (ACTA1) gene. Neuromuscul Disord 11(1):35–40PubMedCrossRef
115.
Zurück zum Zitat de Sanctis JT, Cumbo-Nacheli G, Dobbie D, Baumgartner D (2008) HIV-associated nemaline rod myopathy: role of intravenous immunoglobulin therapy in two persons with HIV/AIDS. AIDS Read. 18(2):90–94PubMed de Sanctis JT, Cumbo-Nacheli G, Dobbie D, Baumgartner D (2008) HIV-associated nemaline rod myopathy: role of intravenous immunoglobulin therapy in two persons with HIV/AIDS. AIDS Read. 18(2):90–94PubMed
116.
Zurück zum Zitat Dewberry RG, Schneider BF, Cale WF, Phillips LH 2nd (1993) Sarcoid myopathy presenting with diaphragm weakness. Muscle Nerve 16(8):832–835PubMedCrossRef Dewberry RG, Schneider BF, Cale WF, Phillips LH 2nd (1993) Sarcoid myopathy presenting with diaphragm weakness. Muscle Nerve 16(8):832–835PubMedCrossRef
117.
Zurück zum Zitat Tanios MA, El Gamal H, Epstein SK, Hassoun PM (2004) Severe respiratory muscle weakness related to long-term colchicine therapy. Respir Care 49(2):189–191PubMed Tanios MA, El Gamal H, Epstein SK, Hassoun PM (2004) Severe respiratory muscle weakness related to long-term colchicine therapy. Respir Care 49(2):189–191PubMed
118.
Zurück zum Zitat Simonds AK (2006) Recent advances in respiratory care for neuromuscular disease. Chest 130(6):1879–1886PubMedCrossRef Simonds AK (2006) Recent advances in respiratory care for neuromuscular disease. Chest 130(6):1879–1886PubMedCrossRef
119.
Zurück zum Zitat Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ (2006) Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 5(2):140–147PubMedCrossRef Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ (2006) Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 5(2):140–147PubMedCrossRef
120.
Zurück zum Zitat Guenther UP, Handoko L, Varon R, Stephani U, Tsao CY, Mendell JR et al (2009) Clinical variability in distal spinal muscular atrophy type 1 (DSMA1): determination of steady-state IGHMBP2 protein levels in five patients with infantile and juvenile disease. J Mol Med 87(1):31–41PubMedCrossRef Guenther UP, Handoko L, Varon R, Stephani U, Tsao CY, Mendell JR et al (2009) Clinical variability in distal spinal muscular atrophy type 1 (DSMA1): determination of steady-state IGHMBP2 protein levels in five patients with infantile and juvenile disease. J Mol Med 87(1):31–41PubMedCrossRef
121.
Zurück zum Zitat Kyriakides T, Papacostas S, Papanicolaou E, Bagdades E, Papathanasiou ES (2011) Sleep hypoventilation syndrome and respiratory failure due to multifocal motor neuropathy with conduction block. Muscle Nerve 43(4):610–614PubMedCrossRef Kyriakides T, Papacostas S, Papanicolaou E, Bagdades E, Papathanasiou ES (2011) Sleep hypoventilation syndrome and respiratory failure due to multifocal motor neuropathy with conduction block. Muscle Nerve 43(4):610–614PubMedCrossRef
122.
Zurück zum Zitat Gracey DR, Southorn PA (1987) Respiratory failure in lambert-eaton myasthenic syndrome. Chest 91(5):716–718PubMedCrossRef Gracey DR, Southorn PA (1987) Respiratory failure in lambert-eaton myasthenic syndrome. Chest 91(5):716–718PubMedCrossRef
123.
Zurück zum Zitat Nicolle MW, Stewart DJ, Remtulla H, Chen R, Bolton CF (1996) Lambert-eaton myasthenic syndrome presenting with severe respiratory failure. Muscle Nerve 19(10):1328–1333PubMedCrossRef Nicolle MW, Stewart DJ, Remtulla H, Chen R, Bolton CF (1996) Lambert-eaton myasthenic syndrome presenting with severe respiratory failure. Muscle Nerve 19(10):1328–1333PubMedCrossRef
124.
Zurück zum Zitat Ohno K, Tsujino A, Brengman JM, Harper CM, Bajzer Z, Udd B et al (2001) Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. Proc Natl Acad Sci USA 98(4):2017–2022PubMedCentralPubMedCrossRef Ohno K, Tsujino A, Brengman JM, Harper CM, Bajzer Z, Udd B et al (2001) Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. Proc Natl Acad Sci USA 98(4):2017–2022PubMedCentralPubMedCrossRef
125.
Zurück zum Zitat Milone M, Shen XM, Selcen D, Ohno K, Brengman J, Iannaccone ST et al (2009) Myasthenic syndrome due to defects in rapsyn: clinical and molecular findings in 39 patients. Neurology 73(3):228–235PubMedCentralPubMedCrossRef Milone M, Shen XM, Selcen D, Ohno K, Brengman J, Iannaccone ST et al (2009) Myasthenic syndrome due to defects in rapsyn: clinical and molecular findings in 39 patients. Neurology 73(3):228–235PubMedCentralPubMedCrossRef
Metadaten
Titel
Diagnosis of muscle diseases presenting with early respiratory failure
verfasst von
Gerald Pfeffer
Marcus Povitz
G. John Gibson
Patrick F. Chinnery
Publikationsdatum
01.05.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 5/2015
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-014-7526-1

Weitere Artikel der Ausgabe 5/2015

Journal of Neurology 5/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.